Candel Therapeutics, Inc. Common Stock
$11.02
Market Cap
$843.23M
Shares Outstanding
76.5M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Jul 27, 2021
Round Lot
100
Locale
US
Day Open
$11.16
Day High
$11.43
Day Low
$10.83
Volume
1.17M
VWAP
$11.12
Prev Close
$11.12
Transactions
--
Acc. Volume
--
Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
Candel Therapeutics, Inc. Common Stock (CADL) closed the 2026-09-16 session at $11.02, down 0.90% versus the previous close (-0.10). The stock opened at $11.16 and traded between $10.83 and $11.43 during that session. Session trading volume was 1.2M shares. The volume-weighted average price (VWAP) is $11.12.
Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
Candel Therapeutics, Inc. Common Stock has a market capitalization of $843.2 million. The company operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) industry classification. CADL is listed on the XNAS exchange. The company employs approximately 55 people. Candel Therapeutics, Inc. Common Stock is headquartered in NEEDHAM, MA. The recorded listing date is 2021-07-27.
On this page you can find market CADL stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.